Happy Anniversary!

Margaret Tempero
Search for other papers by Margaret Tempero in
Current site
Google Scholar
Full access

I always get a little sad in December. To start with, my birthday is in September, and I’m not getting any younger. It’s also the end of the year, and I have to face the fact that I didn’t get everything done that I wanted to. Finally, I walk into my clinic each day realizing that this will be the last holiday season for many of my patients. That’s a part of the circle of life, but it never seems right at this time of year.

This December, though, I have something new to distract me from these realities. First, in January we’re going to launch a new format for JNCCN. We put a lot of thought into this, and I really hope that it’s something that you, our readers, will embrace. Of course, we’re still going to publish the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) and related reviews. But we’re also going to publish more examples of putting molecular medicine into practice. Further, we will focus the publication on the highest quality original research in the areas of health services, outcomes, quality improvement, and policy. In addition, at least for 2015, we’ll have one really special extra feature.

This coming year, 2015, is the 20th anniversary of the founding of NCCN. Under the leadership of Joe Simone, MD, 13 institutions banded together with the goal of identifying strategies to protect our academic missions in oncology. If you weren’t part of the discussion at the time, you might be surprised at NCCN’s original goals. In fact, as we charted our strategy, one of the first initiatives was to harmonize practice across the institutions. From this, the NCCN Guidelines were born.

As a founding board member, I’ve been privileged to watch the growth, maturation, and evolution of NCCN over 2 decades. We’ve done many things very well and have struggled with other issues, as all organizations do. And we’ve grown! NCCN now has 25 Member Institutions, with many other institutions waiting to join the queue. Even though NCCN isn’t quite what we originally envisioned, it’s been a clear success story by any measurement.

To celebrate this anniversary, throughout 2015, JNCCN will feature a guest editorial each month from individuals who have special insights on NCCN. Most of these editorials will be contributions from former and current NCCN leaders, giving us a collection of viewpoints with both historical and future perspectives. Of course, we’ll ask Joe Simone to kick this off. I think you will find these commentaries rich with thoughtful perspectives about NCCN, our academic institutions, and the bigger world of oncology, both in science and in the community.

I think it’s important to sit back from time to time and look at where you’ve been and think about where you’re going. We’ll devote time next year just for that. And maybe when December rolls around again, I’ll feel just a little bit better.

Dr. Tempero is a Professor of Medicine and Director of the UCSF Pancreas Center, and the editor-in-chief of JNCCN. Her research career has focused on pancreatic ductal adenocarcinoma especially in the area of investigational therapeutics.

Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She co-directed the AACR/ASCO Methods in Clinical Cancer Research and taught this course and similar courses in Europe and Australia. She was founding Chair of the NCI Clinical Oncology Study Section (CONC) and served as a member and chair of the NCI Board of Scientific Counselors Subcommittee A. She is on the External Advisory Boards of the Pancreas SPOREs at Mayo Clinic and at UAB/Minnesota and the GI SPORE at the University of Arizona. She is, or has been, on the Scientific Advisory Boards of the Lustgarten Foundation, the Pancreatic Cancer Action Network, the V Foundation, The Alberta Canada Cancer Board, and the EORTC. She served as a member of the Oncology Drug Advisory Committee for the FDA.

She has served as Deputy Director and Interim Director for the UNMC Eppley Cancer Center. She is Chief Emeritus of the Division of Medical Oncology at UCSF and served as Deputy Director and Director of Research Programs at the UCSF Helen Diller Family Comprehensive Cancer Center.

The ideas and viewpoints expressed in this editorial are those of the author and do not necessarily represent any policy, position, or program of NCCN.

  • Collapse
  • Expand
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 143 29 15
PDF Downloads 127 31 5
EPUB Downloads 0 0 0